Search for an epigenetic biomarker in ADHD diagnosis, based on the DAT1 gene 5'-UTR methylation: a new possible approach

Psychiatry Res. 2020 Sep:291:113154. doi: 10.1016/j.psychres.2020.113154. Epub 2020 May 30.

Abstract

Attention Deficit/Hyperactivity Disorder (ADHD) is the most common neuro-developmental alteration in childhood. To date, its diagnosis is exclusively clinical, however recent studies focused on searching for objective biomarkers. We recently reported a selective alteration of DNA methylation in the 5'-UTR of dopamine transporter (DAT1) gene, in a 1CGG2CGG3CGG and a 5CG6CG motif, for ADHD patients (compared to controls). Presently, we looked for DNA methylation of the corresponding CpG sites but complementary on the opposite strand ("COS"). Exploiting a novel cross-correlation approach, we found a core M5 - M5 COS and M2 - M2 COS relationship with relatively free M1 and M6 COS extremes. Our data might be relevant, to find a new biomarker to diagnose ADHD in affected subjects.

Keywords: 5’-UTR motifs; CpG epigenetic marker; DNA opposite strand; Dopamine transporter (DAT).

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / diagnosis*
  • Attention Deficit Disorder with Hyperactivity / genetics*
  • Child
  • Cohort Studies
  • DNA Methylation / genetics*
  • Dopamine Plasma Membrane Transport Proteins / genetics*
  • Epigenesis, Genetic / genetics*
  • Female
  • Genetic Markers / genetics
  • Humans
  • Male

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Genetic Markers
  • SLC6A3 protein, human